Cleveland BioLabs Accounts Payable

Cleveland BioLabs (CBLI) currently reports a accounts payable of $61K as of June 2021. That compares with $300K in the prior-year period — down 79.9% year over year. Use the charts on this page to explore Cleveland BioLabs's accounts payable history and peer comparisons.

Cleveland BioLabs's accounts payable decreased from $300K to $61K — a 79.9% year-over-year decrease (period ending June 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cleveland BioLabs reported $61K in accounts payable as of June 2021. That compares with $300K in the prior-year period — down 79.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $61K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cleveland BioLabs, and consider following CBLI for alerts when major investors trade the stock.

Cleveland BioLabs is classified in the Healthcare sector. On accounts payable, it currently shows $61K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CBLI with unrelated industries.